The Long COVID-19 Wearable Device Study

Recruiting N/A Interventional Study
Long COVID Postural Orthostatic Tachycardia Syndrome Dysautonomia Myalgic Encephalomyelitis Chronic Fatigue Syndrome Long Covid19
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
100,500 (estimated)
Sponsor
Scripps Translational Science Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Is at least 18 years old. * Has a self/and or physician diagnosis of: * Long COVID (based on the WHO working definition), * ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or * POTS (Postural Orthostatic Tachycardia Synd…
Contacts

Andrea Goosen

0000000000

agoosen@scripps.edu

CONTACT

Romina Foster-Bonds

rfoster@scripps.edu

CONTACT